HARP
Harpoon Therapeutics Inc

1,422
Loading...
Loading...
Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company, which engages in the development of antibodies. It focuses on the research of novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases. The firm utilizes its proprietary Tri-specific T cell Activating Construct platform to create a pipeline of novel TriTACs for the treatment of solid tumors and hematologic malignancies. The company was founded by Patrick A. Baeuerle, Luke B. Evnin, and Jeanmarie Guenot on March 19, 2015 and is headquartered in South San Francisco, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is the 52-week high for Harpoon Therapeutics Inc?
What is the 52-week low for Harpoon Therapeutics Inc?
What is Harpoon Therapeutics Inc stock price today?
What was Harpoon Therapeutics Inc stock price yesterday?
What is the 50-day moving average of Harpoon Therapeutics Inc?

Latest HARP News

View

Advertisement. Remove ads.

Advertisement. Remove ads.